The design and characterisation of ITK irreversible inhibitors

William Kerr, Sébastien André Campos, John D Harling

Research output: Contribution to conferenceSpeech

Original languageEnglish
Publication statusPublished - 18 Jul 2013
Event1st GSK/University of Strathclyde MPhil/PhD Symposium - GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom
Duration: 18 Jul 201318 Jul 2013

Conference

Conference1st GSK/University of Strathclyde MPhil/PhD Symposium
CountryUnited Kingdom
CityStevenage
Period18/07/1318/07/13

Keywords

  • ITK inhibitors
  • irreversible inhibitors
  • interleukin-2-inducible T-cell kinase

Cite this